Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Production & Manufacturing
Return to: PBR Home | Production & Manufacturing
Today in Production & Manufacturing

Production & Manufacturing

Merck agrees to buy Cubist Pharmaceuticals for $9.5bn Merck has entered into a definitive agreement to acquire antibiotics maker Cubist Pharmaceuticals in a deal, which includes an equity valuation of $8.4bn and $1.1bn in net debt and other considerations. Production & Manufacturing > Manufacturing > News

Latest Production & Manufacturing News by Sector

Select a sector from the list or browse by sector below:

Fine & Speciality Chemicals

Bayer plans to focus entirely on Life Science businesses
Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health.
News
CordenPharma agrees to purchase Peptisyntha from Solvay
By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.
News

Process & Production

Aldeyra Therapeutics submits FDA IND filing for noninfectious anterior uveitis
Aldeyra Therapeutics, a biotechnology company focused on the development of products to treat diseases related to free aldehydes, announced that an Investigational New Drug application (IND) to conduct Phase 2 clinical testing of NS2 for the treatment of noninfectious anterior uveitis, was submitted to the United States Food and Drug Administration (FDA) on December 16, 2014.
News
Bayer files BLA for BAY 81-8973 to treat Hemophilia A in adults and children
By PBR Staff Writer
Bayer HealthCare has submitted a biologics license application (BLA) to the US Food and Drug Administration (FDA) seeking approval for BAY 81-8973, a recombinant Factor VIII (rFVIII) compound, to treat hemophilia A in children and adults.
News

OTC

NutraFuels receives purchase order from RC Taylor distributing
NutraFuels, manufacturer of oral spray dietary supplements, announced that the company has received and fulfilled its first purchase order from R.C. Taylor Distributing.
News
Iodine launches cold and flu app to helps smart consumers find best OTC options for their symptoms
Iodine, a developer of health information website Iodine.com, has launched a new web app for cold and flu season.
News

Manufacturing

Yew Bio-Pharm to enter US health supplement market with two agaric polysaccharide products
Yew Bio-Pharm Group announced that it is entering into the US health supplement market, through a collaboration with an American health supplement company to research and develop agaric polysaccharide (black fungus extract) and its related health supplements, which will be produced in the U.S. and sold to both American and Chinese markets. The new products are expected to launch in the first half of 2015.
News
Mettrum gets Health Canada license at its Agripharm facility
Mettrum Health, parent company of Mettrum, a licensed producer of medical cannabis under the Marihuana for Medical Purposed Regulations (Canada) issued pursuant to the Controlled Drugs and Substances Act (Canada) (the MMPR) and a vertically integrated agri-pharmaceutical company focused on research, development, production and distribution of medical cannabis products, is pleased to announce that the Company's subsidiary, Agripharm, has received a license from Health Canada to produce marijuana under the MMPR.
News